Susquehanna International Group
CRBU icon

Susquehanna International Group’s Caribou Biosciences CRBU Stock Holding History

Susquehanna International Group’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$308K Buy
162,100
+147,800
+1,034% +$254K ﹤0.01% 10796
2025
Q4 		$22.7K Sell
14,300
-7,600
-35% -$16K ﹤0.01% 11929
2025
Q3 		$51K Buy
21,900
+7,600
+53% +$14.3K ﹤0.01% 11855
2025
Q2 		$18K Buy
+14,300
New +$14.1K ﹤0.01% 12350
2025
Q1 		– Sell
-14,400
Closed -$22.9K – 12596
2024
Q4 		$22.9K Buy
+14,400
New +$29K ﹤0.01% 11896
2024
Q3 		– Sell
-14,500
Closed -$23.8K – 12114
2024
Q2 		$23.8K Sell
14,500
-26,000
-64% -$83.1K ﹤0.01% 11622
2024
Q1 		$208K Buy
+40,500
New +$250K ﹤0.01% 10517
2023
Q4 		– Sell
-59,400
Closed -$284K – 12464
2023
Q3 		$284K Buy
59,400
+44,100
+288% +$274K ﹤0.01% 9473
2023
Q2 		$65K Buy
15,300
+3,200
+26% +$14.4K ﹤0.01% 11216
2023
Q1 		$64.3K Sell
12,100
-63,200
-84% -$394K ﹤0.01% 11577
2022
Q4 		$473K Sell
75,300
-36,900
-33% -$328K ﹤0.01% 8014
2022
Q3 		$1.18M Buy
112,200
+51,400
+85% +$479K ﹤0.01% 6196
2022
Q2 		$330K Buy
+60,800
New +$465K ﹤0.01% 9316
2022
Q1 		– Sell
-29,700
Closed -$448K – 13093
2021
Q4 		$448K Buy
+29,700
New +$578K ﹤0.01% 9482

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group's CRBU Position: Q1 2026 in Review

Susquehanna International Group reduced its Caribou Biosciences (CRBU) stake by 19% in Q1 2026, selling an estimated $334K and leaving 836,903 shares worth $1.59M. The position accounts for ﹤0.01% of the portfolio, ranked #6711.

Susquehanna International Group first reported a position in CRBU in Q4 2021 and has held it in 17 quarters since. The position peaked at $1.64M in Q4 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • Susquehanna International Group held 836,903 shares of Caribou Biosciences worth $1.59M as of Q1 2026.
  • Susquehanna International Group sold 194,472 Caribou Biosciences shares in Q1 2026, an estimated $334K.
  • Caribou Biosciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6711 holding.
  • Susquehanna International Group first reported a position in Caribou Biosciences in Q4 2021 and has held it in 17 quarters since.
  • Susquehanna International Group's Caribou Biosciences position peaked at $1.64M in Q4 2025.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.